Publication:
Real-Life Outcomes of Ocrelizumab Treatment from 3 Multiple Sclerosis Centers in Turkey

dc.contributor.authorVural, E.
dc.contributor.authorTerzi, M.
dc.contributor.authorSunter, G.
dc.contributor.authorGunal, D.
dc.contributor.authorAgan, K.
dc.contributor.authorBoz, C.
dc.date.accessioned2020-06-21T12:26:01Z
dc.date.available2020-06-21T12:26:01Z
dc.date.issued2019
dc.departmentOMÜen_US
dc.department-temp[Vural, E. -- Sunter, G. -- Gunal, D. -- Agan, K.] Marmara Univ, Neurol, Istanbul, Turkey -- [Terzi, M.] Ondokuz Mayis Univ, Neurol, Samsun, Turkey -- [Boz, C.] Karadeniz Tech Univ, Neurol, Trabzon, Turkey --en_US
dc.description35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS -- SEP 11-13, 2019 -- Stockholm, SWEDENen_US
dc.description.abstracten_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis, Congrex Switzerland Ltden_US
dc.identifier.endpage751en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.startpage751en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10630
dc.identifier.volume25en_US
dc.identifier.wosWOS:000485303103164
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleReal-Life Outcomes of Ocrelizumab Treatment from 3 Multiple Sclerosis Centers in Turkeyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files